PRE-SALE IS LIVELearn More
What is Aimedis?
Aimedis is the next generation e-health platform which will connect the efficiency of AI and the
security of Blockchain to provide cutting edge medical and psychological support. Aimedis is a
platform which will enable patients and doctors to connect with each other 24/7 from
everywhere on the planet while offering never before seen security for patient's personal medical
and psychological data.
The dual blockchain design
The Aimedis security system is based on a dual blockchain architecture, allowing Aimedis users
to keep ownership of their medical data while allowing them to monetize their private data for
medical research purposes or pay for medical services and medication while getting great
discounts by using the AIM token. Medical researchers will be granted only as much or as little
confidential data as desired by the patient in a completely anonymized way, protecting the
patient's sensitive information while allowing them to both profit and contribute to medical
research. The AIMchain private blockchain will make trust visible for the patient and the users
and will finally empower the patient via decentralisation and incentivising.
Connected Patient Communities
Aimedis helps connect patients in to communities using a unique social network system.
Aimedis will provide a dedicated space for patients to share their experiences,
recommendations, feedback, and advice with other patients. By coming together as a
community, patient's benefit from sharing their experiences and in offering support to each other.
This helps in dealing with acceptance and treatment of medical conditions.
The members of this community will have rich media capabilities such as uploading video,
audio, text, or image content, allowing them to connect with their peers. This media and content
is part of a creation-incentivized rewards system where creators of high quality content can be
rewarded by the other community members with votes.
As a community, members will be able to offer financial incentives (via voting) for content
published on the platform. Patient's can use their tokens to pay for services, transact within the
community, or exchange to fiat.
Secondarily, this content will be used as data inputs for our Artificial Intelligence when creating
extensive reports on specific medical conditions and diagnosis. This data is appended
alongside wearables data, scientific data, and more.
? 20% of Aimedis revenue will directly flow into the AIMsocial fund
? Token can be used to pay services inside the platform and medication in the
AIMedisafe backed online drugstore with discounts
? Token will be used to reward participants in terms of sharing usefully voted content
on AIMsocial - our own medical social network
? The token enables the user to contribute to content creators via upvote + direct
? Researchers will pay patients for participating in trials via the token
? Token issuance during presale and ICO via Swisscom blockchain portal, which will
issue them directly after contribution
? Legal surveillance by Wenger & Vieli attorneys at law, Zürich & Zug, Switzerland
Already a proven existing company
Aimedis is an existing company, which operates today in three countries:
Germany, Netherlands and Thailand.
Aimedis works today with several hospital chains as a technology provider
working with medical data, and has helped more than ten thousand patients.
Aimedix's team members.
Founder & CEO
Founder & COO